Text Size

Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2007 by National Cancer Institute (NCI).
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00383279
First received: September 29, 2006
Last updated: May 9, 2009
Last verified: October 2007
History of Changes

September 29, 2006
May 9, 2009
February 2006
December 2007   (final data collection date for primary outcome measure)
  • Development of a structured interview instrument [ Designated as safety issue: No ]
  • Recruitment strategy [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00383279 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
Improving Employment Among Gynecologic Cancer Survivors

RATIONALE: Finding out which problems affect employment in survivors of gynecologic cancer may help in planning cancer treatment and improve the quality of life of future cancer survivors.

PURPOSE: This research study is looking at ways to improve employment in patients who have survived cervical cancer, uterine cancer, or ovarian cancer.

OBJECTIVES:

  • Conduct formative work, including 4 to 5 focus groups, leading to development of a structured interview instrument assessing factors related to employment outcomes among women with gynecologic cancers.
  • Pilot a recruitment strategy and administer the interview among a sample of 60 to 70 gynecologic cancer survivors; and, with each woman's permission, a family member, a key health care provider, and her supervisor will be interviewed.

OUTLINE: This is a multicenter, pilot study.

Patients complete a survey, meet with a focus group, and undergo a short interview. Patient-designated participants are also interviewed; these individuals may include a health care provider, a significant other, and/or a work supervisor.

PROJECTED ACCRUAL: A total of 70 patients will be accrued for this study.
Interventional
Not Provided
Not Provided
  • Cervical Cancer
  • Ovarian Cancer
  • Sarcoma
  • Other: counseling intervention
  • Other: study of socioeconomic and demographic variables
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
70
Not Provided
December 2007   (final data collection date for primary outcome measure)

DISEASE CHARACTERISTICS:

  • Diagnosis of 1 of the following invasive cancers:

    • Cervical cancer
    • Uterine cancer
    • Ovarian cancer
  • Diagnosed ≥ 6 months ago
  • Any stage disease
  • Employed at the time of diagnosis, defined as working for pay ≥ 20 hours/week

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
Female
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00383279
CDR0000491031, CCCWFU-99106, CCCWFU-BG06-014
Not Provided
Not Provided
Wake Forest University
National Cancer Institute (NCI)
Principal Investigator: Brigitte E. Miller, MD Comprehensive Cancer Center of Wake Forest University
National Cancer Institute (NCI)
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP